Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 336–336 | Cite as

Osimertinib

Acquired drug resistance: case report
Case report
  • 12 Downloads

Reference

  1. Yang Z, et al. Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient. Targeted Oncology 14: 369-374, No. 4, Aug 2019. Available from: URL: http://doi.org/10.1007/s11523-019-00652-6 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations